0
Skip to Content
B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
B+ | Fighting Childhood Cancer
ABOUT
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
GET INVOLVED
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
RESEARCH
RESEARCH
OVERVIEW
RESEARCH GRANTS
NEED HELP?
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
Folder: ABOUT
Back
ABOUT
OVERVIEW
ANDREW'S STORY
CHILDHOOD CANCER FACTS
FINANCIALS
Folder: GET INVOLVED
Back
GET INVOLVED
B+ EVENTS
STUDENTS & SCHOOL EVENTS
INDIVIDUAL EVENTS
B+ HEROES
ALUMNI & PROFESSIONALS
PARTNERS & SPONSORS
INVITE JOE TO SPEAK
WAYS TO GIVE
ANDREW'S CHAMPIONS FOR HOPE
Folder: RESEARCH
Back
RESEARCH
OVERVIEW
RESEARCH GRANTS
Folder: NEED HELP?
Back
NEED HELP
FAMILY ASSISTANCE
PSYCHOSOCIAL SUPPORTS
TESTIMONIALS
BLOG
MERCH
DONATE
Therapeutic downregulation of core circuitry genes in mutant MYOD1 rhabdomyosarcoma
Midwest, Ohio Julia Travagline 11/20/24 Midwest, Ohio Julia Travagline 11/20/24

Therapeutic downregulation of core circuitry genes in mutant MYOD1 rhabdomyosarcoma

Therapeutic downregulation of core circuitry genes in mutant MYOD1 rhabdomyosarcoma

Dr. Berkley Gryder, Ph.D. – Case Western Reserve University School of Medicine, Cleveland, OH

Read More
Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy
Midwest, Ohio Julia Travagline 12/14/22 Midwest, Ohio Julia Travagline 12/14/22

Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy

Investigating the role of PSAT1 in tumor-associated macrophages for sarcoma immunotherapy

Case Western Reserve University - School of Medicine, Cleveland, OH

Read More
First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma
Midwest, Ohio Julia Travagline 12/8/21 Midwest, Ohio Julia Travagline 12/8/21

First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma

First-in-class oral inhibitor of TGF-beta receptor in humanized mouse model of advanced osteosarcoma

Case Western Reserve University School of Medicine, Cleveland, OH

Read More
Polycomb inhibition sensitizes AML to anthracycline therapy
Ohio, Midwest Julia Travagline 8/10/21 Ohio, Midwest Julia Travagline 8/10/21

Polycomb inhibition sensitizes AML to anthracycline therapy

Polycomb inhibition sensitizes AML to anthracycline therapy

The Research Institute at Nationwide Children’s Hospital, Columbus, OH

Read More
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
Ohio, Midwest Julia Travagline 8/9/21 Ohio, Midwest Julia Travagline 8/9/21

‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients

‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients

Cincinnati Children’s Hospital, Cincinnati, OH

Read More
Reversing NK Cell Dysfunction in Pediatric Cancer
Ohio, Midwest Julia Travagline 8/9/21 Ohio, Midwest Julia Travagline 8/9/21

Reversing NK Cell Dysfunction in Pediatric Cancer

Reversing NK Cell Dysfunction in Pediatric Cancer

Case Western Reserve University, Cleveland, OH

Read More

HELPFUL LINKS

BLOG

RESEARCH

SCHOOLS

COMPANIES

FACTS

PRIVACY

ABOUT

B+ EVENTS

B+ HEROES

HERO FUNDS

B+ GEAR

GET ASSISTANCE

 

CONNECT WITH US

Address: The B+ Foundation
101 Rockland Circle
Wilmington, DE 19803

Phone: 302.563.8389 | 845.304.6347
Email: Joe@BePositive.org | Carly@BePositive.org

Family Assistance: Katie@BePositive.org | 609.330.6775

 
Today-logo.png
 
ICRP-logo copy.jpg
 

CONTACT US

Name *
Thank you!

 The Andrew McDonough B+ Foundation is an IRS-certified 501(c)3 organization. Our Tax ID # is 42-1741037.

B+® is a registered trademark